Li Y - Search Results

1

Correction: Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.

Jia K, Chen Y, Sun Y, Hu Y, Jiao L, Ma J, Yuan J, Qi C, Li Y, Gong J, Gao J, Zhang X, Li J, Zhang C, Shen L. Jia K, et al. Among authors: li y, li j. BMC Med. 2023 Sep 29;21(1):369. doi: 10.1186/s12916-023-03090-4. BMC Med. 2023. PMID: 37775728 Free PMC article. No abstract available.

2

Comparative analysis of dideoxy sequencing, the KRAS StripAssay and pyrosequencing for detection of KRAS mutation.

Gao J, Li YY, Sun PN, Shen L. Gao J, et al. World J Gastroenterol. 2010 Oct 14;16(38):4858-64. doi: 10.3748/wjg.v16.i38.4858. World J Gastroenterol. 2010. PMID: 20939116 Free PMC article.

3

Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.

Gao J, Lu M, Yu JW, Li YY, Shen L. Gao J, et al. BMC Cancer. 2011 May 18;11:177. doi: 10.1186/1471-2407-11-177. BMC Cancer. 2011. PMID: 21586171 Free PMC article.

4

[Mutations of KRAS and BRAF in Chinese patients with colorectal carcinoma: analyses of 966 cases].

Gao J, Sun ZW, Li YY, Shen L. Gao J, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Sep;41(9):579-83. doi: 10.3760/cma.j.issn.0529-5807.2012.09.002. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 23157823 Chinese.

5

[Association between miR-34a expression and recurrence after radical resection of colorectal cancer].

Li S, Li YY, Gao J, Shen L. Li S, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jan;16(1):60-5. Zhonghua Wei Chang Wai Ke Za Zhi. 2013. PMID: 23355243 Chinese.

6

Wild-Type KRAS and BRAF Could Predict Response to Cetuximab in Chinese Colorectal Cancer Patients.

Gao J, Wang TT, Yu JW, Li YY, Shen L. Gao J, et al. Chin J Cancer Res. 2011 Dec;23(4):271-5. doi: 10.1007/s11670-011-0271-4. Chin J Cancer Res. 2011. PMID: 23357879 Free PMC article.

7

[Correlation of MDR1 and ABCG2 genetic polymorphisms with the efficacy and adverse events of irinotecan chemotherapy in patients with colorectal cancer].

Sun ZW, Wang XC, Gao J, Li J, Li YY, Dang YZ, Shen L. Sun ZW, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jun;16(6):524-8. Zhonghua Wei Chang Wai Ke Za Zhi. 2013. PMID: 23801203 Chinese.

8

Dbx2 exhibits a tumor-promoting function in hepatocellular carcinoma cell lines via regulating Shh-Gli1 signaling.

Hu YT, Li BF, Zhang PJ, Wu D, Li YY, Li ZW, Shen L, Dong B, Gao J, Zhu X. Hu YT, et al. World J Gastroenterol. 2019 Feb 28;25(8):923-940. doi: 10.3748/wjg.v25.i8.923. World J Gastroenterol. 2019. PMID: 30833799 Free PMC article.

9

Trastuzumab Combined with Irinotecan in Patients with HER2-Positive Metastatic Colorectal Cancer: A Phase II Single-Arm Study and Exploratory Biomarker Analysis.

Xu T, Wang X, Xin Y, Wang Z, Gong J, Zhang X, Li Y, Ji C, Sun Y, Zhao F, Huang D, Bai Y, Li J, Shen L. Xu T, et al. Among authors: li y, li j. Cancer Res Treat. 2023 Apr;55(2):626-635. doi: 10.4143/crt.2022.1058. Epub 2022 Dec 23. Cancer Res Treat. 2023. PMID: 36550683 Free PMC article. Clinical Trial.

10

Multidimensional immune profiling in Gastric Cancer Multiplex Immunohistochemistry Atlas from Peking University Cancer Hospital project informs PD-1/PD-L1 blockade efficacy.

Jia K, Chen Y, Xie Y, Chong X, Li Y, Wu Y, Yuan J, Li Y, Feng X, Hu Y, Sun Y, Gong J, Zhang X, Li J, Shen L. Jia K, et al. Among authors: li y, li j. Eur J Cancer. 2023 Aug;189:112931. doi: 10.1016/j.ejca.2023.05.019. Epub 2023 Jun 1. Eur J Cancer. 2023. PMID: 37343324 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240,258 results

Search Page

Filters